BioSpace News Archive

PDS Biotechnology Corporation, a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, announced that clinical research conducted by the NCI, one of the Institutes of the National Institutes of Health, was published in the peer-reviewed journal, International Immunopharmacology.

ProSomnus, Inc. (“the Company”) (NASDAQ: OSA ), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the appointment of Brian Dow as Chief Financial Officer, effective March 1, 2023.

Myriad Genetics, Inc. announced its support for the first evidence-based expanded carrier screening practice guidelines for reproductive risk assessment published by the National Society of Genetic Counselors in the Journal of Genetic Counseling.

Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will participate in an Ovarian Cancer panel discussion at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023, at 9:10 a.m. ET / 6:10 a.m. PT in Boston, MA.

Foghorn ® Therapeutics Inc. today announced that it will participate at Cowen’s 43rd Annual Health Care Conference, which is taking place March 6–8, 2023, at the Boston Marriott Copley Place in Boston, MA.

PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today reported financial results for the full year ended December 31, 2022, and provided a corporate update.

NewAmsterdam Pharma Company N.V. today announced that Michael Davidson, M.D., chief executive officer of NewAmsterdam Pharma, will present at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 2:50 p.m. ET.

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, will report financial results for the full year ending December 31, 2022 on Wednesday, March 1, 2023 after the stock market close, and host a conference call on Thursday, March 2, 2023 at approximately 9:00 a.m. EST.

Catalyst Pharmaceuticals, Inc. announced that it will release its fourth quarter and full-year 2022 financial results after the market close on Wednesday, March 15, 2023.

IN8bio, Inc. today announced William Ho, CEO and co-founder, will present a company overview at the Cowen 43rd Annual Healthcare Conference on Tuesday, March 7, 2023 at 12:50 pm ET.